Topics

Adding a cancellation field to temporal interference stimulation reduces off-target effects in mouse tests and strengthens its potential for treating neurological disorders.

A targeted RNA therapy restored brain function in a myotonic dystrophy type 1 model, marking a breakthrough for rare genetic disease treatment.

Researchers used the internet to send drugs and light into a rat brain from another continent, seeking longer studies with less disruption to the animal.

Scientists identified microglia as the hidden cause of Alzheimer's sleep loss, restoring sleep without removing amyloid plaques in a breakthrough Alzheimer's treatment study.

This study uses brain recordings to recreate what mice see, revealing how visual information is processed and potentially aiding research on perception across species.

Alzheimer's candidate KCL-286 repairs neuronal DNA damage, cuts neuroinflammation in mice. Safe for humans, this amyloid alternative targets multiple pathways.

Noland Arbaugh, the first person to receive a Neuralink brain implant in January, speaks about his experience and expectations.

Soft hydrogel sensors offer better fit and signal quality for future neural monitoring applications.

Yale researchers found two brain-cell proteins that let toxic alpha-synuclein travel between neurons, paving the way for first treatments that slow Parkinson’s rather than just managing symptoms.

Brain-inspired AI may revolutionize artificial intelligence after neuroscientists uncovered biological decision-making mechanisms that could make deep learning faster, smarter, and dramatically more efficient.